School of Kinesiology, University of Minnesota, Minneapolis, Minnesota, USA.
Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Exp Physiol. 2024 Sep;109(9):1593-1603. doi: 10.1113/EP091715. Epub 2024 Aug 2.
The purpose of this study was to determine the effect of circulating microvesicles isolated from chronic electronic (e-)cigarette users on cultured human umbilical vein endothelial cell (HUVEC) expression of nuclear factor-κB (NF-κB), cellular cytokine release, phosphorylation of endothelial nitric oxide synthase (eNOS) and NO production. The HUVECs were treated with microvesicles isolated via flow cytometry from nine non-tobacco users (five male and four female; 22 ± 2 years of age) and 10 e-cigarette users (six male and four female; 22 ± 2 years of age). Microvesicles from e-cigarette users induced significantly greater release of interleukin-6 (183.4 ± 23.6 vs. 150.6 ± 15.4 pg/mL; P = 0.002) and interleukin-8 (160.0 ± 31.6 vs. 129.4 ± 11.2 pg/mL; P = 0.01), in addition to expression of p-NF-κB p65 (Ser536) (18.8 ± 3.4 vs. 15.6 ± 1.5 a.u.; P = 0.02) from HUVECs compared with microvesicles from non-tobacco users. Nuclear factor-κB p65 was not significantly different between microvesicles from the non-tobacco users and from the e-cigarette users (87.6 ± 8.7 vs. 90.4 ± 24.6 a.u.; P = 0.701). Neither total eNOS (71.4 ± 21.8 vs. 80.4 ± 24.5 a.u.; P = 0.413) nor p-eNOS (Thr495) (229.2 ± 26.5 vs. 222.1 ± 22.7 a.u.; P = 0.542) was significantly different between microvesicle-treated HUVECs from non-tobacco users and e-cigarette users. However, p-eNOS (Ser1177) (28.9 ± 6.2 vs. 45.8 ± 9.0 a.u.; P < 0.001) expression was significantly lower from e-cigarette users compared with non-tobacco users. Nitric oxide production was significantly lower (8.2 ± 0.6 vs. 9.7 ± 0.9 μmol/L; P = 0.001) in HUVECs treated with microvesicles from e-cigarette users compared with microvesicles from non-tobacco users. This study demonstrated increased NF-κB activation and inflammatory cytokine production, in addition to diminished eNOS activity and NO production resulting from e-cigarette use. HIGHLIGHTS: What is the central question of this study? Circulating microvesicles contribute to cardiovascular health and disease via their effects on the vascular endothelium. The impact of electronic (e-)cigarette use on circulating microvesicle phenotype is not well understood. What is the main finding and its importance? Circulating microvesicles from e-cigarette users increase endothelial cell inflammation and impair endothelial nitric oxide production. Endothelial inflammation and diminished nitric oxide bioavailability are central factors underlying endothelial dysfunction and, in turn, cardiovascular disease risk. Deleterious changes in the functional phenotype of circulating microvesicles might contribute to the reported adverse effects of e-cigarette use on cardiovascular health.
本研究旨在确定从慢性电子(e-)香烟使用者中分离的循环微泡对培养的人脐静脉内皮细胞(HUVEC)核因子-κB(NF-κB)表达、细胞细胞因子释放、内皮型一氧化氮合酶(eNOS)磷酸化和 NO 产生的影响。使用流式细胞术从 9 名非烟草使用者(5 名男性和 4 名女性;22 ± 2 岁)和 10 名电子烟使用者(6 名男性和 4 名女性;22 ± 2 岁)中分离微泡,然后用微泡处理 HUVEC。与非烟草使用者的微泡相比,电子烟使用者的微泡诱导白细胞介素-6(183.4 ± 23.6 与 150.6 ± 15.4 pg/mL;P = 0.002)和白细胞介素-8(160.0 ± 31.6 与 129.4 ± 11.2 pg/mL;P = 0.01)的释放以及 HUVEC 中 p-NF-κB p65(Ser536)(18.8 ± 3.4 与 15.6 ± 1.5 a.u.;P = 0.02)的表达显著增加。与非烟草使用者的微泡相比,NF-κB p65 在来自非烟草使用者和电子烟使用者的微泡之间没有显著差异(87.6 ± 8.7 与 90.4 ± 24.6 a.u.;P = 0.701)。总 eNOS(71.4 ± 21.8 与 80.4 ± 24.5 a.u.;P = 0.413)和 p-eNOS(Thr495)(229.2 ± 26.5 与 222.1 ± 22.7 a.u.;P = 0.542)在非烟草使用者和电子烟使用者的微泡处理 HUVEC 之间也没有显著差异。然而,与非烟草使用者相比,p-eNOS(Ser1177)(28.9 ± 6.2 与 45.8 ± 9.0 a.u.;P < 0.001)的表达显著降低。与非烟草使用者的微泡相比,电子烟使用者的微泡处理的 HUVEC 中一氧化氮的产生明显降低(8.2 ± 0.6 与 9.7 ± 0.9 μmol/L;P = 0.001)。本研究表明,电子烟的使用会导致 NF-κB 激活和炎症细胞因子产生增加,同时内皮型一氧化氮合酶活性和 NO 产生减少。